NCT03941184 Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity Status COMPLETED Phase N/A
NCT03914638 Beta-agonist Efficacy and Tolerability as Adjuvant Therapy in Myasthenia Gravis Status UNKNOWN Phase PHASE2/PHASE3
NCT03905161 Rhythmic Auditory Stimulation and Walking Speed in the 6-minute Walk Test Status COMPLETED Phase N/A
NCT03900585 Can Interval Walking Influence on Fatigue in the Danish Cohort of Myasthenia Gravis Patients Status WITHDRAWN Phase NA
NCT03759366 A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG) Status COMPLETED Phase PHASE3
NCT03743740 The Effect of Spinal Stabilization Exercises in Patients With Myasthenia Gravis Status COMPLETED Phase NA
NCT03613272 The Curative Effect of Extended Thymectomy Performed Through Subxiphoid-right VATS Approach With Elevation of Sternum Status UNKNOWN Phase NA
NCT03597373 Variables Predicting Reintubation After Thymectomy in Patients With Myasthenia Gravis Status UNKNOWN Phase N/A
NCT03510546 Effect of Pyridostigmine (Mestinon) on Muscle Strength in Myasthenia Gravis Status UNKNOWN Phase PHASE4
NCT03052751 Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis Status COMPLETED Phase PHASE2
NCT02965573 A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness Status COMPLETED Phase PHASE2